関連する実験動画
Updated: Jul 24, 2026
13:12
Efficient Gene Delivery into Multiple CNS Territories Using In Utero Electroporation
Published on: June 23, 2011
ゲミニ表面活性物質によって媒介されるトランスフェクション:エンドソーム区間から人工的に脱出する
Paul C Bell1, Mark Bergsma, Igor P Dolbnya
1Contribution from the Physical Organic Chemistry Unit, Stratingh Institute, University of Groningen, 4 Nijenborgh, 9747 AG Groningen, The Netherlands.
Journal of the American Chemical Society
|February 6, 2003
まとめ
砂糖ベースのジェミニ表面活性剤1は,ユニークなリポプレックス構造を形成する. pHによって誘発された逆向六角形相へのシフトは,DNA放出のためのエンドソームを中断することによって,遺伝子配送を強化します.
科学分野:
- バイオ物理化学 バイオ物理化学
- マテリアルサイエンス 材料科学
- 遺伝子配送システムとは
背景:
- DNAとカチオンの表面活性物質から形成されるリポプレックスは,遺伝子配送に不可欠です.
- リポプレックス形態の理解は,トランスフェクションの効率を最適化するための鍵です.
- 砂糖ベースのジェミニ表面活性剤は,改良された遺伝子配送手段の可能性を秘めています.
研究 の 目的:
- DNA/gemini表面活性物質の構造変化を調査するために,1はpHの範囲にわたってリポプレックスする.
- リポプレックス形質と表面活性物質の構造とトランスフェクションの有効性を相関させる.
- ジェミニ表面活性剤によって促進されるpH誘発の遺伝子放出のメカニズムを解明する 1.
主な方法:
- リポプレックス構造を分析するための小角X線散射 (SAXS).
- 形態学の高解像度イメージングのための冷凍電子顕微鏡 (冷凍TEM).
- 表面活性物質の特徴を観察された構造とリンクするための分子モデリング.
主要な成果:
- 3つの異なるリポプレックス形態が観察されました:ラメラー,凝縮ラメラー,逆転六角形 (H ((II)) 段階.
- 形態学に影響を与える重要な表面活性物質の特徴 (スペース長,発射可能な窒素,不飽和の尾,砂糖のヘッドグループ) を特定した.
- エンドソームのpHで,pH誘発によるH (III) 段階への移行が実証されています.
結論:
- ジェミニ表面活性剤1は,調節可能な形態学を持つpH反応性リポプレックスを形成する.
- エンドソームのpHでH(II) 段階への移行は,エンドソームの不安定化とDNAの放出を促進します.
- このpHが誘発するメカニズムは,ゲミニ表面活性剤1の遺伝子伝達における高トランスフェクション効率を説明する.
関連する概念動画
01:28The Early Endosome: Endocytosis of Transferrin
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
00:58Recycling Endosomes and Transcytosis
The recycling endosome, also known as the endosomal recycling compartment (ERC), is a part of the slow-recycling process of the endocytic pathway. Molecules internalized through receptor-mediated endocytosis are either degraded in the lysosomes or are recycled to the plasma membrane through the fast- or slow-recycling route.
The recycling endosome is not a single organelle but an extensively tubulated network of recycling pathways. It functions in storing molecules or transporting them across...
The recycling endosome is not a single organelle but an extensively tubulated network of recycling pathways. It functions in storing molecules or transporting them across...
01:19Membrane Asymmetry Regulating Transporters
Enzymes like flippase, floppase, and scramblase transfer phospholipids from one layer to another in the membrane, thereby affecting membrane asymmetry.
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:23Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
01:06Carrier-Mediated Transport
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...